For: | Liszka Ł, Zielińska-Pająk E, Pająk J, Gołka D, Starzewski J, Lorenc Z. Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy. World J Gastroenterol 2007; 13(4): 515-524 [DOI: 10.3748/wjg.v13.i4.515] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i4/515.htm |
Number | Citing Articles |
1 |
Rob Glynne Jones, David Tan. How can we determine the best neoadjuvant chemoradiotherapy regimen for rectal cancer?. Colorectal Cancer 2015; 4(1): 37 doi: 10.2217/crc.15.3
|
2 |
Hiroshi Doi, Naohito Beppu, Soichi Odawara, Masao Tanooka, Yasuhiro Takada, Yasue Niwa, Masayuki Fujiwara, Fumihiko Kimura, Hidenori Yanagi, Naoki Yamanaka, Norihiko Kamikonya, Shozo Hirota. Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer. Journal of Radiation Research 2013; 54(6): 1118 doi: 10.1093/jrr/rrt058
|